-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
NHS Solutions
-
Life Sciences Industry
-
Advancing UK Healthcare
-
Pharmacy Communications
NHS Solutions
Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn MoreNHS Solutions
Life Sciences Industry
We believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn MoreLife Sciences Industry Solutions
Advancing UK Healthcare
We are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn MoreAdvancing UK Healthcare Solutions
Pharmacy Communications
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn MoreBLOGS, WHITEPAPERS & CASE STUDIES
Explore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
Learn More
White Paper
Just What the Doctor Ordered?
An analysis of the UK Life Sciences Industrial Strategy and Sector Deal in the context of the UK’s withdrawal from the European Union
Jul 19, 2018
“Brexit could provide UK Life Sciences with the opportunity to become a global leader in the uptake of innovative medicines”
A new white paper by IQVIA and Public Policy Projects (PPP) analyses the ability of the Life Sciences Industrial Strategy and Sector Deal to meet the challenges raised by Brexit. Where there are gaps, it specifically calls on the Government to place these issues at the centre of the deal it seeks during negotiations with EU partners. The white paper demonstrates the value of medicines through the use of Real-World Evidence and how the UK’s unique health data ecosystem can position it as the global leader in this evolving science, benefitting NHS patients and payers alike.
It makes 9 recommendations:
- The UK should continue to have a 'deep and special relationship' with the EU, including membership of the EMA
- The UK needs to secure free trade and free movement of medicines with the EU
- The UK government should commit to making non-identified patient-level data more readily available for appropriate commercial research
- The UK should position itself as a destination for inward pharmaceutical investment
- The UK government should consult and introduce clinical research performance metrics aligned with global standards to improve clinical trial success rates and predictability
- The UK should maintain access arrangements for the best talent from across the global scientific community
- The UK government should increase spending on research to 2.4 per cent of GDP by 2027 and maintain ongoing engagement with the successor to the EU's research funding programme, Horizon 2020.
- The Life Sciences Industrial Strategy Implementation Committee should deliver an accelerated national plan for Digital Innovation Hubs, focusing on interoperability
- Improved collaboration and engagement with industry across the NHS and research landscape